VOICED : Una quinta parte de la población mundial podría no tener acceso a la vacuna hasta 2022

A study by Johns Hopkins University highlights that one in five people worldwide may have to wait until 2022 for a COVID-19 vaccine, as wealthy countries have already secured over half of the 2021 doses. The study assumes optimal vaccine development and production, with a total of 5.96 billion doses expected in 2021. Vaccine prices range from $6 to $74, and up to 40% of doses could be available for low- and middle-income countries, depending on distribution by wealthier nations. The COVAX initiative, led by WHO and other organizations, aims to ensure global vaccine access, targeting 2 billion doses by the end of 2021, though the US and Russia have not joined.

What new insight or understanding did you gain from this video?